Sickle Cell Disease study: Music Therapy
Official title Assessing Molecular Mechanisms and Effects of Music Therapy in Youth With Sickle Cell Disease Using Single-cell RNA-sequencing
ClinicalTrials.gov ID: NCT07562451
What this study is testing
- What it's testing
- This study is testing whether a 4‑week music therapy program can lower pain and improve quality of life in young people with sickle cell disease.
- Who it's for
- You may be able to join if you are a young person with sickle cell disease.
- What's involved
- You would attend music therapy sessions for four weeks. You will also have blood tests to look at immune cells.
- Time commitment
- The study lasts about four weeks with weekly visits for therapy and a few blood draws.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 18
You may be able to join if
- Diagnosed with SCD
- English fluency (for survey completion)
- Have access to a personal electronic device (e.g., phone, tablet) with access to the internet
- Persistent or recurrent for ≥ 3 months
- is associated with significant emotional distress or functional disability.30
You likely can't join if
- Major hearing deficiency or medical condition in which listening to music may be contraindicated (e.g., reflex epilepsy).
The study team makes the final eligibility decision.
Where it is enrolling
- Atlanta, Georgia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Atlanta, Georgia, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.